compound oral tirzepatide Tirzepatide Injection | Starts at

Clinical trials demonstrate that discontinuation of semaglutide typically results in gradual weight regain, with patients recovering approximately two-thirds of lost weight within one year of stopping treatment, according to STEP trial extension data

342 Surgical approaches for affected patients include marsupialization, which can be conducted in instances of clinically symptomatic lymphocele or cases that fail to respond to percutaneous drainage and sclerosis

This introductory dose allows your body to adjust to the medication before increasing to higher maintenance doses that may produce greater weight loss and metabolic benefits

Discuss your options with a healthcare provider to determine the best approach for your weight management strategy